UK allows pre-implantation tissue typing
This article was originally published in Clinica
Executive Summary
The Human Fertilisation and Embryology Authority (HFEA) has decided, "in principle", to allow tissue typing to be used in conjunction with preimplantation genetic diagnosis (PGD) for "severe genetic disease". The decision enables the selection of embryos that are not only free from a specific congenital disease but in which the blood from its umbilical cord might be used in the treatment of a sibling affected by the disease.